MedPath

studying to role of urinary neutrophil associated gelatinase biomarker as an early predictor of acute kidney injury in patients treated with antibiotic Colisti

Not Applicable
Conditions
Health Condition 1: null- critically ill patients
Registration Number
CTRI/2018/02/012036
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

all patients with age 18 years or more who are planned for colistin therapy

Exclusion Criteria

1.Refusal of consent

2.History of chronic renal disease

3.Acute kidney injury features accordingg to RIFLE criteria

4.Recent contrast dye exposure(within 5 days)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To study pattern of changes in urinary neutrophil gelatinase associated lipocalin after administration of colistin <br/ ><br>2.To compare serum creatinine and urinary neutrophil gelatinase associated lipocalin levels for prediction of acute kidney injury in patientsTimepoint: At completion recruitment
Secondary Outcome Measures
NameTimeMethod
1.To identify factors associated for colistin induced Acute kidney injuryTimepoint: At completion of recruitment
© Copyright 2025. All Rights Reserved by MedPath